Transforming the €40+ billion chronic wound care market

Faster wound healing powered by electricity

Electrodes that accelerates wound healing with direct current and produces actionable healing data, moving care from passive management to active repair

our in vitro data

See electric healing in action

At Bioelectrix, we believe the future of wound care is electric.

Our patented wound electrodes delivers gentle direct current to reactivate stalled healing.

In this video we show how wounded cells react to stimulation with our technology. Resulting in 3x faster closure of a wound in healthy and diabetic human skin cells. 

The problem

Chronic wounds are a major global healthcare burden; the likelihood of developing them rises with diabetes, obesity, and age

0 M+

people worldwide suffer from chronic wounds

“Chronic wounds are overlooked in the health care system. Old age, obesity and diabetes are making this worse.”

> 0 %

mortality in 5 years for Diabetic Foot Ulcers

“Once a wound has become chronic, time starts ticking for patients unless they can be cured…”

0 B€+

spent per year on chronic wounds

“We need better, cost-effective treatments for these wounds that can actively stimulate the healing process

Electric fields steer cells to repair tissue; in chronic wounds, the guidance fails

The Solution

From passive wound care to active healing. A new class of bioelectronic wound therapy

Bioelectrix is building a new class of wound care solution combining active bioelectric healing stimulation with real-time monitoring, designed to accelerate healing and create measurable outcomes for clinicians and payers alike.

Active healing at biological level

Restores natural electric fields guiding skin repair

Designed to accelerate closure in hard-to-heal wounds

Built for real world healthcare systems

Designed to reduced treatment duration and care costs

Fits existing wound care workflows and reimbursement logic

A scalable bioelectronic platform

Initial focus on diabetic foot ulcers

Expandable to other chronic and acute wounds

WHY NOW?

For decades, the biology of electric wound healing has been understood, but not solved. We know we need to apply direct current, but we have not solved this from a material perspective

Materials and bioelectronics have reached clinical maturity

Only recently have metal free conductive materials and fabrication methods enabled safe, stable direct current stimulation on human tissue, overcoming the electrochemical limitations that blocked earlier approaches.

Chronic wounds have become a systemic healthcare crisis

Ageing populations and rising diabetes prevalence are driving an unprecedented increase in chronic wounds, creating urgency for solutions that actively accelerate healing rather than passively manage symptoms.

Healthcare systems are ready for outcome driven therapies

Payers and providers are increasingly prioritizing treatments that shorten care pathways, reduce complications, and enable outpatient management, creating a clear entry point for active, cost-effective wound therapies.

Bioelectrix sits at the intersection of these shifts, translating decades of bioelectric science into a clinically and commercially viable product

Latest news

Bioelectrix named Disruptor of the Year 2026 🏆

Bioelectrix has won the national Disruptor of the Year pitch competition at Innovation Night in Uppsala, taking the title and SEK 100,000 for its bioelectronic approach to chronic wound care.

Bioelectrix selected for HealthTech Venture Pulse 2026

Bioelectrix has been selected as one of twelve companies to present at HealthTech Venture Pulse 2026, bringing together some of Sweden’s most promising healthtech ventures with leading Nordic investors. More

Bioelectrix won Falling Walls Lab Gothenburg

We are proud to share that Bioelectrix has won Falling Walls Lab Gothenburg 2026, hosted by Chalmers University of Technology, with the pitch “Breaking the Wall of Bioelectric Wound Healing.” This recognition

shaping the future of healing